New guidelines for PET scan use in trials & in monitoring treatments
http://interactive.snm.org/index.cfm?PageID=5302
Enacting Recommendations Could Result in a More Efficient Evaluation of FDG PET as a Biomarker, Lead to Shorter Clinical Trials and Improved Treatment for Cancer Patients |
All times are GMT -7. The time now is 04:07 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021